In our opinion,compounds possessing higher affinity for CAIX and sufficient selectivityover remaining CA isozymes, such as GZ22-4, are advantageousto visualize CAIX-positive tumors and could be further developed byattaching PET probes, other radioactive elements, for both visualizationand cancer treatment. The gene discussed is CA9; the disease is cancer.